US Drug Recall Register
Class I · High risk Terminated Initiated Sep 27, 2011 (15 years ago)

metFORMIN ER Tablets

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Labeling: Label Mix up; product labeled did not indicated Extended Release

What was recalled

metFORMIN ER Tablets, 500 mg, Rx, Packaged and labeled as metFORMIN Immediate Release (IR), Repackaged By: Shamrock Medical Solutions Lewis Center, Ohio, Mfr: Amneal/Interpharm, Hauppauge, NY NDC 53746-178-01

Recalling firm
Shamrock Medical Solutions Group LLC
NDC code
53746-178-01
Origin
OH, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1448-2014

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Metformin recalls

See all
Class II · Moderate risk Ongoing

Synjardy XR Tablets

Reason CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a different product.

Boehringer Ingelheim Pharmaceuticals, Inc. D-0657-2026
Class II · Moderate risk Terminated

Metformin Hydrochloride Extended-Release Tablets

Reason Presence of Foreign Tablets/Capsules: A Paracetamol 500 mg tablet was found in a 1000-count bottle of Metformin HCL ER Tablets USP, 500 mg.

Granules Pharmaceuticals Inc. NDC 82009-117-10 D-0192-2025
Class II · Moderate risk Terminated

Metformin hydrochloride Extended-Release Tablets

Reason CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.

Teva Pharmaceuticals USA Inc NDC 00591-2720-60 D-0441-2023